Inspiring transformational change in the

field of oncology diagnostics


To develop and deliver accurate, rapid, minimally

invasive oncology diagnostic products utilising our

patented MCM5 antibodies

Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.

Latest News


- 9 hours ago

The nominees for the Medilink Northern Powerhouse Healthcare Business Awards are out, and #ArquerDiagnostics are th…

- 17 hours ago

Check out Arquer's mention in the latest industry analyst report on cancer diagnostics! We are proud to have been n…

- 1 day ago

#ArquerDiagnostics is pleased to announce that we will be exhibiting and presenting in Copenhagen next month at the…